- ￥100 - 9999
- Biolegend
- 美国
- 329919
- 2025年07月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
蓝冰
- 规格：
25 tests
Brilliant Violet 421™ anti-human CD279 (PD-1)参数介绍>>>>
| Clone | EH12.2H7 |
| Isotype | Mouse IgG1, κ |
| Reactivity | Human, Cross-Reactivity: Chimpanzee, Common Marmoset, Rhesus12, Squirrel Monkey, Cynomolgus |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA). |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™ under optimal conditions. The solution is free of unconjugated Brilliant Violet 421™ and unconjugated antibody. |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining, the suggested use of this reagent is ≤5 µl per million cells or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application. |
| Applications | FC - Quality tested |
| Application Notes | Additional reported applications (for the relevant formats) include: blocking of ligand binding1-3. The LEAF™ purified antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 329911 and 329912). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 329926) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg). " |
| Application References | 1. Dorfman DM, et al. 2006 Am. J. Surg. Pathol. 30:802. (FA) |
| Description | The program death 1 (PD-1) receptor CD279 is a 55 kD member of the immunoglobulin superfamily. CD279/PD-1 contains the immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic region and plays a key role in peripheral tolerance and autoimmune disease. CD279/PD-1 is expressed predominantly on activated T cells, B cells and myeloid cells. PD-L1 (B7-H1) and PD-L2 (B7-DC) are ligands of CD279/PD-1 and are members of the B7 gene family. Evidence reported to date suggests overlapping functions for these two PD-1 ligands and their constitutive expression on some normal tissues and upregulation on activated antigen-presenting cells. Interaction of CD279:PD-ligands results in inhibition of T cell proliferation and cytokine secretion. |
| Storage | The antibody solution should be stored undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. |
品牌介绍：Biolegend公司自2002年成立以来，一直致力于为生物医药研究领域提供一流的，高质量的流式抗体、试剂盒及其它相关产品。公司聚集了一批来自PharMingen的专业杰出人士，建立了一支雄厚技术背景的专业队伍，并通过其自身的先天优势，以及与世界知名实验室和研究所的良好合作关系，以最合理的价格为广大客户提供卓越的免疫学和细胞生物学产品，并不断地开发新产品，以满足飞速发展的生命科学研究的需要。短短几年时间，Biolegend公司得到了飞速发展，已跻身全球最先进的抗体公司行列，并在2009年成为美国哈佛大家的独家抗体供应商！ Biolegend公司的试剂主要包括细胞免疫、细胞因子、趋化因子、粘附分子等及与癌症研究、T 调节细胞研究、干细胞研究、先天免疫研究、细胞周期分析、凋亡研究及特定修饰类抗体等领域相关的试剂，用于流式、ELISA、免疫沉淀、WB、免疫荧光、免疫组化、及体内体外功能学试验。其中，Biolegend公司的流式抗体以其具有较宽范围的荧光选择及较高的性价比，为广大科研工作者所接受！同时，公司配备了一支经验丰富的技术服务队伍，为客户提供完美的配色方案及快速的售后处理服务！
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验不只是 PD-1：CD96 正成为免疫治疗的下一个“必争之地”
, Markus Mezger.(2023). CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells. [14] Chelsia Qiuxia Wang, F. C. Choy, A. Sanny, Takashi Murakami, A. Tan, K. Lam.(2023). An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor
这种水果将助力癌症治疗？增强免疫治疗效果，有望克服 PD-1 耐药难题！
素 C、花青素类物质，已被证明可以通过增加肠道中嗜粘液杆菌（A.muciniphila）和双歧杆菌（Bifidobacterium）的丰度，对小鼠的肥胖和相关代谢紊乱发挥保护性作用。 2022 年 1 月 14 日，来自加拿大蒙特利尔大学研究中心的 Bertrand Routy 团队在 Cancer Discovery 上发表了题为 A natural polyphenol exerts antitumor activity and circumvents anti-PD-1 resistance
一年内两次叫停！康方CD73单抗又“悬”了，PD-1的黄金搭档还香吗？
肿瘤免疫治疗中，PD-1/L1抑制剂单药响应率有限，寻找“黄金搭档”成为焦点。CD73曾被视为最具潜力的免疫代谢靶点之一——它通过催化产生腺苷，在肿瘤微环境中形成免疫抑制屏障，阻断CD73有望“解放”T细胞，与PD-1联用实现增效。 然而理想丰满，现实骨感。2026年3月11日，外媒报道康方生物暂停了CD73单抗（drebuxelimab）联合依沃西单抗治疗非小细胞肺癌的Ib/II期研究（AK119-201），官方称“研发战略优先级调整”。这已是康方第二次叫停CD73相关试验——2025年2月
技术资料暂无技术资料 索取技术资料
